FORCI, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 566
EU - Europa 262
AS - Asia 161
Totale 989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 564
IE - Irlanda 70
CN - Cina 63
IT - Italia 51
SE - Svezia 48
PL - Polonia 44
HK - Hong Kong 40
JO - Giordania 29
RU - Federazione Russa 29
SG - Singapore 14
CH - Svizzera 5
GB - Regno Unito 5
SA - Arabia Saudita 5
UA - Ucraina 5
IR - Iran 4
DE - Germania 3
KR - Corea 3
CA - Canada 2
FI - Finlandia 2
VN - Vietnam 2
IN - India 1
Totale 989
Salva come PNG Salva come JPEG
Città #
Fairfield 91
Dublin 70
Chandler 64
Ashburn 48
Warsaw 44
Woodbridge 36
Seattle 34
Beijing 28
Cambridge 28
Lawrence 28
Altamura 26
Hong Kong 26
Houston 24
Wilmington 22
Princeton 19
Buffalo 14
Kent 14
Boston 13
Florence 11
Shanghai 11
Singapore 9
San Diego 7
Dearborn 6
Medford 6
Ann Arbor 5
Bern 5
Norwalk 5
Riyadh 5
New York 4
Hefei 3
Seoul 3
Boardman 2
Dong Ket 2
Foggia 2
Forlì 2
Fuzhou 2
Guangzhou 2
Moscow 2
Redwood City 2
Rome 2
Andover 1
Carate Brianza 1
Chengdu 1
Hebei 1
Hillsboro 1
Jiaxing 1
Jinan 1
Kunming 1
Lappeenranta 1
London 1
Montréal 1
Mumbai 1
Nanjing 1
Olbia 1
Redmond 1
Shenzhen 1
Toronto 1
Wenzhou 1
Wuhan 1
Ürümqi 1
Totale 747
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 104
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 101
Bilateral isolated facial palsy with fast recovery in infectious mononucleosis 93
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 87
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 71
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 59
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 58
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 55
Leptomeningeal enhancement analysis in diagnostic clinical setting 45
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 42
The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course 41
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 40
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 40
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 39
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 38
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 37
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences 34
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 33
Totale 1.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020222 0 3 3 26 27 15 27 32 33 32 20 4
2020/202194 8 9 1 15 10 7 2 11 11 9 8 3
2021/2022110 2 8 6 7 1 5 5 13 6 4 17 36
2022/2023348 29 60 26 9 22 54 43 20 66 0 9 10
2023/2024145 5 15 18 8 18 11 3 30 1 4 22 10
2024/202546 36 10 0 0 0 0 0 0 0 0 0 0
Totale 1.017